Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,204.3
-13.8 (-0.43%)

 

  • STI Straits Times Index
    3,204.3
    -13.8 (-0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    -11.5 (-0.72%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,619.1
    -9.7 (-0.04%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,528.2
    -34.1 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,874.7
    -223.5 (-0.77%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,535.1
    -67.1 (-1.02%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 919.9M
  • Value: 538.9M
  • Rise: 88
  • Fall: 184
  • Unch: 479

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Raffles Edu0.080+0.013
Tritech0.028-0.001
Geo Energy Res0.335-0.050
Beverly JCG0.001-
Shen Yao0.003-
Rex Intl0.330-0.020
Jiutian Chemical0.086-0.003
Oceanus0.041+0.001
Hatten Land0.059-0.001
Metal Component0.061-0.001

World Indices

World Indices
Name Last Change
Nasdaq 15,235.8 +0.1
HSI 25,620.2 -8.6
HSCEI 9,073.2 -20.6
Jakarta 6,535.1 -67.1
Nikkei 225 28,877.4 -220.9
SSE Comp 3,528.2 -34.1
Shanghai A 3,697.8 -35.6
Shanghai B 270.0 -6.2
KOSPI 3,034.1 +8.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALIGOS THERAPEUTICS INC ALIGOS THERAPEUTICS INC
Updated on 27 Oct 2021 (End of trading day)
Last (USD): 16.200 Change: -0.180 High: 16.980 Remarks: -
Change (%): -1.10 Low: 15.445
Open 16.340 Yesterday's Close 16.38
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 117,126 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.54743 Trailing EPS (USD) e -2.93857 NAV (USD) b 3.9636
PE a - Trailing PE f - Price / NAV b 4.0872
Dividend (USD) d - Cash In Hand (USD) g 4.4085 Issued & Paid-up Shares c 42,608,800
Dividend Yield (%) d - Price / Cash In Hand g 3.675 Treasury Shares h -
Market Cap (M) 690.263 Enterprise Value (M) 511.944
Piotroski F Score 2 Exchange Code ALGS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 99.47 Free Float (%) 60.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 10 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 Oct 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALIGOS THERAPEUTICS INC NASDAQ 690.263 - - 4.0872 -
Industry Pharmaceuticals: Major NASDAQ 2,297.333 85.549 91.614 3.3295 0.026
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 191,380.138 59.881 50.751 12.2085 1.879
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 125,260.416 8.923 18.088 1.6703 -
Local Peer ROYALTY PHARMA PLC NASDAQ 22,350.001 22.922 23.005 3.8980 0.521
Local Peer VIATRIS INC NASDAQ 15,841.699 - - 0.7470 -
Local Peer REPLIGEN CORP NASDAQ 14,901.020 248.656 149.110 9.2953 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 8,342.098 - - 10.2320 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 7,486.055 - - 22.0231 -
Local Peer CUREVAC NV NASDAQ 7,147.124 - - - -
Local Peer ALLAKOS INC NASDAQ 5,761.967 - - 10.0913 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,790.454 - - 19.7032 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 5,326.525 - - 5.4088 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 4,767.833 69.882 69.882 5.5411 -
Other Local Peers KARUNA THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ERASCA INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), GOSSAMER BIO INC (NASDAQ), KRONOS BIO INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), GH RESEARCH PLC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), PETIQ INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANNEXON INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), VERU INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), PHARVARIS NV (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), EVOLUS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), CLENE INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), NEXIMMUNE INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), XOMA CORP (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), DURECT CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), IMMUNIC INC (NASDAQ), OBSEVA SA (NASDAQ), INOZYME PHARMA INC (NASDAQ), MUSTANG BIO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), IMARA INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), GALECTO INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), RENOVORX INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), SEQLL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 431,042.275 29.295 24.108 - 2.431
Global Peer PFIZER INC NYSE 240,919.469 25.054 18.213 3.4396 3.535
Global Peer ELI LILLY AND COMPANY NYSE 239,307.869 38.637 39.420 37.1343 1.183
Global Peer MERCK & CO INC NYSE 206,407.910 29.207 37.050 6.1995 3.040
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 201,399.567 24.950 22.418 3.7267 2.330
Global Peer ABBVIE INC NYSE 191,562.312 42.046 29.073 15.2408 4.460
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 187,324.141 29.070 26.313 17.9170 1.273
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 125,526.994 - - 3.4103 3.289
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 101,691.465 13.794 17.145 4.7872 5.119
Global Peer WUXI APPTEC CO LTD HKEx 474,422.879 142.943 102.448 10.7465 0.219
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), ORGANON & CO (NYSE), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CANSINO BIOLOGICS INC (HKEx), SINOPHARM GROUP CO. LTD. (HKEx), REMEGEN CO LTD (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), EVEREST MEDICINES LTD (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), CSTONE PHARMACEUTICALS (HKEx), OCUMENSION THERAPEUTICS (HKEx), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ZYMEWORKS INC (NYSE), IMMUNOTECH BIOPHARM LTD (HKEx), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), Kimia Farma Tbk. (IDX), ABBISKO CAYMAN LTD (HKEx), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), ANTENGENE CORP LTD (HKEx), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), TRANSCENTA HOLDING LTD (HKEx), HUA MEDICINE (HKEx), Soho Global Health Tbk. (IDX), ZHAOKE OPHTHALMOLOGY LTD (HKEx), IGBB (Bursa), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), TOT BIOPHARM INTL CO LTD (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), CYBIN INC (NYSE American), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American),